Quince Therapeutics, Inc. (QNCX): 8-K filed Jul 31, 2026

Form type

8-K

Filing date

Jul 31, 2026

Accession number

0001193125-26-328784

Filer

Quince Therapeutics, Inc. (CIK 1662774)